BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) investors concerning the Company’s possible violations of federal securities laws.
On August 17, 2020, Applied Therapeutics revealed that the U.S. Food and Drug Administration had placed a partial clinical hold on the Company’s ACTION-Kids study, citing the need for additional technical information to ensure that each study participant has access to the drug’s benefits. The ACTION-Kids study is evaluating the Company’s AT-007 drug for the treatment of galactosemia.
On this news, the Company’s shares fell $3.53 per share, or 12.07%, to close at $25.71 per share on August 17, 2020.
If you purchased Applied Therapeutics securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.